Rationing in an era of multiple tight constraints: is cost-utility analysis still fit for purpose? by Dakin, HA, Tsiachristas, A

Economic evaluation of factorial trials: cost-utility analysis of the AFORRD 2x2x2 factorial trial of atorvastatin, omega-3 fish oil and action-planning by Dakin, HA, Farmer, A, Gray, AM, Holman, RR

Statistical and health economic analysis plan for a randomized controlled trial of surgical fixation with K-wires versus plaster casting in the treatment of dorsally displaced dist... by Ooms, AG, Png, ME, Cook, JA, Dritsaki, M, Dakin, HA, Costa, ML

Associations between preoperative Oxford hip and knee scores and costs and quality of life of patients undergoing primary total joint replacement in the NHS England: an observation... by Eibich, P, Dakin, HA, Price, AJ, Beard, DJ, Arden, NK, Gray, AM

Estimating risk factor time paths among people with Type 2 Diabetes and QALY gains from risk factor management by Gao, N, Dakin, HA, Holman, RR, Lim, L-L, Leal, J, Clarke, P

Cost-effectiveness of replacing versus discarding the nail in children with nail bed injury by Dakin, HA, Nguyen, TTA, Dritsaki, M, Greig, AVH, Stokes, JR, Cook, JA, Beard, DJ, Davies, L, Gardiner, MD, Jain, A

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial by Becker, F, Dakin, HA, Reed, SD, Li, Y, Leal, J, Gustavson, SM, Wittbrodt, E, Hernandez, AF, Gray, AM, Holman, RR

A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVA... by Chakravarthy, U, Harding, SP, Rogers, CA, Downes, S, Lotery, AJ, Dakin, HA, Culliford, L, Scott, LJ, Nash, RL, Taylor, J, Muldrew, A, Sahni, J, Wordsworth, S, Raftery, J, Peto, T, Reeves, BC